Library / Peptides / Hormone Optimization / Kisspeptin-10

Emerging evidence · Grade B

Kisspeptin-10

Hormone Optimization

Evidence

Emerging

Route

Intravenous or Subcutaneous injection

Frequency

Single dose or pulsatile administration (research protocols)

Mechanism.

Kisspeptin-10 is the biologically active decapeptide fragment of the kisspeptin family, which are endogenous neuropeptides encoded by the KISS1 gene. Kisspeptin is a master regulator of the hypothalamic-pituitary-gonadal (HPG) axis, acting as the upstream trigger for GnRH release. It has been studied in humans for its ability to stimulate LH and FSH secretion, restore reproductive hormone signaling, and enhance sexual behavior and arousal.

Kisspeptin is the master switch at the very top of your reproductive hormone chain. Rather than replacing any hormone directly, it flips the switch that tells your brain to start the entire cascade — from GnRH to LH/FSH to testosterone or estrogen — like turning on the main breaker in a power grid.

Mechanism · technical

Kisspeptin-10 binds to the KISS1R (GPR54) receptor on GnRH neurons in the hypothalamus, directly stimulating GnRH pulse generation. This triggers downstream LH and FSH release from the pituitary, which in turn stimulates gonadal testosterone or estrogen production. Kisspeptin sits at the very top of the reproductive hormone cascade and integrates metabolic, stress, and circadian signals to regulate fertility. It has also been shown to activate limbic brain regions involved in sexual arousal.

Part 02 · Dosing & administration

How it's taken.

Values below describe how Kisspeptin-10 has been administered in published trials and labeling. Provided for educational purposes only — this is not medical advice and not instructions for self-administration. Consult your healthcare provider before making any health decision.

Standard dose

1-10 nmol/kg IV bolus (research); 6.4 mcg/kg SC (investigational)

Intravenous or Subcutaneous injection · Single dose or pulsatile administration (research protocols)

Duration

Per research protocol

Primarily a research tool for HPG axis investigation. Used in fertility research to trigger ovulation as alternative to HCG. Short half-life (~30 minutes). Not commercially available.

Need help with reconstitution?

Use the free peptide calculator for dilution, unit conversion, and injection volume.

Open calculator

Part 03 · Safety

Side effects, rare serious events, who shouldn't.

Reported side effects

In clinical studies, kisspeptin-10 has been well tolerated with minimal reported adverse effects. Some subjects have reported transient flushing, mild headache, and injection site discomfort. No serious adverse events have been reported in published human trials. Long-term safety data is very limited as most studies are single-dose or short-duration.

Absolute · do not use

Hormone-sensitive cancers (breast, prostate, ovarian, endometrial)

Pregnancy or breastfeeding

Children under 18 (except under endocrinology specialist care for pubertal disorders)

Known hypersensitivity to kisspeptin or any component

Undiagnosed abnormal uterine bleeding

Interactions

GnRH agonists/antagonists (leuprolide, cetrorelix)

Kisspeptin stimulates GnRH release; may interfere with or potentiate GnRH-based therapies

Major

Hormonal contraceptives

Kisspeptin stimulates gonadotropin release which may reduce contraceptive efficacy

Moderate

Testosterone or estrogen replacement

Kisspeptin stimulates endogenous sex hormone production; may lead to supraphysiologic levels

Moderate

Labs to monitor

LH and FSH

Baseline and per protocol

Kisspeptin directly stimulates GnRH and gonadotropin release

Total and Free Testosterone (men) or Estradiol (women)

Baseline and per protocol

Downstream hormonal effects

CMP (Comprehensive Metabolic Panel)

Baseline and every 3 months

General metabolic safety

Prolactin

Baseline

HPG axis modulation can affect prolactin

Part 04 · Research log

Every study we cite.

Each study with its published finding and a plain-language note on limitations or funding.

2014

Kisspeptin as ovulation trigger in IVF

Kisspeptin triggered oocyte maturation with significantly lower OHSS risk than HCG trigger

Small proof-of-concept; promising but needs larger trials

PMID 25267575 ↗

2013

Kisspeptin signaling in reproductive biology

Kisspeptin is the master upstream regulator of GnRH neurons and puberty onset

Well-established foundational research

PMID 23303908 ↗

Part 05 · Cost & access

Where you can get it.

Regulatory status

Kisspeptin-10 is not FDA-approved for any indication and remains primarily an investigational peptide. It is available through some research peptide suppliers and select compounding pharmacies. It is being actively studied in clinical trials for IVF and reproductive endocrinology applications.

The Peptide Column takes no affiliate commission from any source.

Part 06 · Your appointment

Questions to bring.

Could kisspeptin help diagnose or treat my reproductive hormone issues?

How does kisspeptin compare to HCG or clomiphene for stimulating natural testosterone?

Is kisspeptin being used as an IVF trigger at any clinics?

What are the potential benefits of kisspeptin for libido and sexual function?

Is kisspeptin therapy available, or is it still primarily investigational?

Would kisspeptin be appropriate for recovering my HPG axis after steroid use?